558 related articles for article (PubMed ID: 15063454)
1. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
Thornton PL; Ahmed A
J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
[No Abstract] [Full Text] [Related]
2. A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction.
Abdulla J; Abildstrom SZ; Christensen E; Kober L; Torp-Pedersen C
Eur J Heart Fail; 2004 Dec; 6(7):927-35. PubMed ID: 15556055
[TBL] [Abstract][Full Text] [Related]
3. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
Pharmacotherapy; 2000 May; 20(5):495-522. PubMed ID: 10809338
[No Abstract] [Full Text] [Related]
4. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
5. "Systolic and diastolic dysfunction" in heart failure? Time for a new paradigm.
Konstam MA
J Card Fail; 2003 Feb; 9(1):1-3. PubMed ID: 12612866
[No Abstract] [Full Text] [Related]
6. [Diastolic cardiac insufficiency].
Spoto S; Palma Modoni A; De Galasso L
Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
[No Abstract] [Full Text] [Related]
7. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
Vonder Muhll I; Liu P; Webb G
Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076
[TBL] [Abstract][Full Text] [Related]
8. From left ventricular dysfunction to heart failure.
Cleland JG
Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of heart failure and preserved systolic function].
Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
[No Abstract] [Full Text] [Related]
10. Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.
Buckberg GD;
Heart Fail Rev; 2004 Oct; 9(4):347-51. PubMed ID: 15886980
[No Abstract] [Full Text] [Related]
11. Managing patients with heart failure: the reality of clinical practice.
Squire I
Eur Heart J; 2005 Dec; 26(24):2611-3. PubMed ID: 16219652
[No Abstract] [Full Text] [Related]
12. Remodeling in systolic heart failure: therapeutic implications.
Chatterjee K
Indian Heart J; 2004; 56(2):99-109. PubMed ID: 15377130
[No Abstract] [Full Text] [Related]
13. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
Novosel MK; Haghfelt TH
Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
[TBL] [Abstract][Full Text] [Related]
14. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
Tabrizchi R
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):157-60. PubMed ID: 15030275
[No Abstract] [Full Text] [Related]
15. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
Manoria PC; Manoria P
J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221
[TBL] [Abstract][Full Text] [Related]
16. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
[TBL] [Abstract][Full Text] [Related]
17. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
Rapp JA; Gheorghiade M
Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
[No Abstract] [Full Text] [Related]
18. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches.
J Card Fail; 1999 Dec; 5(4):357-82. PubMed ID: 10634677
[No Abstract] [Full Text] [Related]
19. Heart failure survival score in patients with Chagas disease: correlation with functional variables.
Ritt LE; Carvalho AC; Feitosa GS; Pinho-Filho JA; Macedo CR; Vilas-Boas F; Andrade MV; Feitosa-Filho GS; Almeida AJ; Barojas M; Lopes RD
Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):538-43. PubMed ID: 22513344
[TBL] [Abstract][Full Text] [Related]
20. Heart failure: recent advances in prevention and treatment.
Fonarow GC
Rev Cardiovasc Med; 2000; 1(1):25-33, 54. PubMed ID: 12457149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
